These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 4473014)

  • 1. L-dopa and tricyclic antidepressants in affective disorders. A pilot study.
    Kabes J; Taussigová D; Dostál T; Vinar O
    Act Nerv Super (Praha); 1974 Aug; 16(3):186-8. PubMed ID: 4473014
    [No Abstract]   [Full Text] [Related]  

  • 2. Confusional states in elderly mental patients treated with antidepressants.
    Thomasová E; Mlcáková K; Kümpel Q
    Act Nerv Super (Praha); 1974 Aug; 16(3):189-90. PubMed ID: 4425279
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of a combination nortriptyline-amitriptyline and placebo on gastrointestinal diseases in a controlled clinical study.
    Vrazda L; Langos J; Blazícek P; Vencel P; Pekár S
    Act Nerv Super (Praha); 1973 May; 15(2):115-6. PubMed ID: 4584771
    [No Abstract]   [Full Text] [Related]  

  • 4. Tricyclic antidepressants and depletion of brain catecholamines. Preclinical and clinical studies with L-DOPA [proceedings].
    Kabes J; Pöschlová N; Krsiak M; Dostal T; Masek K; Volsan O
    Act Nerv Super (Praha); 1976; 18(3):242-3. PubMed ID: 1007873
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Effective dosage of tricyclic antidepressants.
    Coppen A; Montgomery S; Lyle WH
    Br Med J; 1975 Jan; 1(5949):91-2. PubMed ID: 1109670
    [No Abstract]   [Full Text] [Related]  

  • 6. [L-dopa therapy for Parkinsonism and its relationship to surgical methods of treatments].
    Vasin NIa; Il'inskiĭ IA; Safronov VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(5):701-6. PubMed ID: 4454895
    [No Abstract]   [Full Text] [Related]  

  • 7. [Side-effects of L-dopa therapy].
    Girke W; Xenakis Ch
    Dtsch Med Wochenschr; 1975 Oct; 100(42):2165-9. PubMed ID: 1100342
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical trial with oxytryptan in depressions].
    Ruiz Ruiz M; Herrera D; Buil R; Lafuente M; Samada P; Zeledón F; Lillo JL
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1981; 9(4):325-30. PubMed ID: 7032243
    [No Abstract]   [Full Text] [Related]  

  • 9. Tricyclic antidepressants and monoamine oxidase inhibitors.
    Schuckit M; Robins E; Feighner J
    Arch Gen Psychiatry; 1971 Jun; 24(6):509-14. PubMed ID: 5578096
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-depressive treatment in Parkinson's disease. A controlled trial of the effect of nortriptyline in patients with Parkinson's disease treated with L-DOPA.
    Andersen J; Aabro E; Gulmann N; Hjelmsted A; Pedersen HE
    Acta Neurol Scand; 1980 Oct; 62(4):210-9. PubMed ID: 7010875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of the cardiotoxicity of tricyclic antidepressants to their membrane effects.
    Elonen E
    Med Biol; 1974 Dec; 52(6):415-23. PubMed ID: 4444361
    [No Abstract]   [Full Text] [Related]  

  • 12. An evaluation of fluphenazine with nortriptyline in anxiety and depression.
    Anderson J; Lambert NG; Pigott PV
    Practitioner; 1972 Apr; 208(246):511-7. PubMed ID: 4555519
    [No Abstract]   [Full Text] [Related]  

  • 13. Reliability of commercially available tricyclic antidepressant levels.
    Amsterdam JD; Brunswick DJ; Mendels J
    J Clin Psychiatry; 1980 Jun; 41(6):206-7. PubMed ID: 7380819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does fluoxetine aggravate Parkinson's disease? A pilot prospective study.
    Montastruc JL; Fabre N; Blin O; Senard JM; Rascol O; Rascol A
    Mov Disord; 1995 May; 10(3):355-7. PubMed ID: 7651460
    [No Abstract]   [Full Text] [Related]  

  • 15. EEG sleep and tricyclic blood levels: acute and chronic administration in depression.
    Kupfer DJ; Hanin I; Coble PA; Spiker DG; Sorisio D; Grau TG
    J Clin Psychopharmacol; 1982 Feb; 2(1):8-13. PubMed ID: 7068946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels and clinical improvement--a comparative study of clomipramine and amitriptyline in depression.
    Moyes IC; Ray RL; Moyes RB
    Postgrad Med J; 1980; 56 Suppl 1():127-9. PubMed ID: 7393822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative evaluation of nortriptyline, amitriptyline and of a placebo in the treatment of anxiety and depressive disorders].
    Taverna P; Ferrari G
    Minerva Med; 1969 Jun; 60(49):2417-31. PubMed ID: 5802654
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of a decarboxylase inhibitor (Ro 4-4602) in combination with L-dopa on inhibited depressions].
    Matussek N; Benkert O; Schneider K; Otten H; Pohlmeier H
    Arzneimittelforschung; 1970 Jul; 20(7):934-5. PubMed ID: 4918921
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and quantitative electroencephalographical effects of MK 940.
    Gannon P; Itil T; Keskiner A; Hsu B
    Arzneimittelforschung; 1970 Jul; 20(7):971-4. PubMed ID: 4918922
    [No Abstract]   [Full Text] [Related]  

  • 20. Preliminary clinical experience with L-dopa in endogenous depressions.
    Náhunek K; Svestka J; Kamenická V; Rodová A
    Act Nerv Super (Praha); 1972; 14(2):101-2. PubMed ID: 4557141
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.